J Exp Clin Cancer Res 2009, 28: 85.CrossRefPubMed 12. Lee NP, Chen L, Lin MC, Tsang FH, Yeung C, Poon RT, Peng J, Leng X, Beretta L, Sun S, Day PJ, Luk JM: Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. J Proteome Res 2009, 8 (3) : 1293–303.CrossRefPubMed 13. Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH: Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res 2008, 14 (7) : 470–477.CrossRefPubMed 14. Tugendreich S, Tomkiel

J, Earnshaw W, Hieter P: CDC27Hs colocalizes with CDC16Hs to the centrosome and mitotic spindle and is essential for the metaphase to anaphase transition. Cell 1995, 81 (2) : 261–268.CrossRefPubMed 15. Fan CW, Chan CC, Chao CC, Fan HA, Sheu DL, Chan EC: Expression patterns of cell cycle and apoptosis-related TGF-beta inhibitor genes in a multidrug-resistant human colon carcinoma cell line. Scand J Gastroenterol 2004, 39 (5) : 464–469.CrossRefPubMed 16. Whyte L, Huang YY, Torres K, Mehta RG: Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses.

Cancer Res 2007, 67 (24) : 12007–12017.CrossRefPubMed 17. Kato M, Yamashina S, Takeda N, Mochizuki S, Morishita T, Nagano M: Molecular biological and quantitative abnormalities of ADP/ATP carrier protein in cardiomyopathic hamsters. Eur Heart J 1995, 16 (Suppl O) : 78–80.PubMed 18. Schulze K, Schultheiss HP: The role of the ADP/ATP carrier in the pathogenesis Chk inhibitor of viral heart disease. Eur Heart J 1995, 16 (Suppl O) : 64–67.PubMed 19. Leirdal M, Shadidy M, Røsok Ø, Sioud M: Identification of genes differentially expressed in breast cancer cell line SKBR3: potential identification of new prognostic biomarkers. Int J Mol Med 2004, 14 (2) : 217–222.PubMed 20. Vogt DL, Gray CD, Young WS 3rd, Orellana SA, Malouf AT: ARHGAP4 is a novel RhoGAP that mediates inhibition of cell motility and axon outgrowth. Mol Cell Neurosci 2007, 36

(3) : 332–342.CrossRefPubMed 21. Nagaraja GM, Kandpal RP: Chromosome Chlormezanone 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins. Biochem Biophys Res Commun 2004, 313 (3) : 654–665.CrossRefPubMed 22. Ullmannova V, Popescu NC: Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detect Prev 2007, 31 (2) : 110–118.CrossRefPubMed 23. Wong CM, Yam JW, Ching YP, Yau TO, Leung TH, Jin DY, Ng IO: Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res 2005, 65 (19) : 8861–8868.CrossRefPubMed 24.